Genolution Inc. (KOSDAQ:225220)

Genolution Statistics

Total Valuation

Genolution has a market cap or net worth of KRW 39.20 billion. The enterprise value is 29.85 billion.

Market Cap	39.20B
Enterprise Value	29.85B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Genolution has 18.07 million shares outstanding. The number of shares has decreased by -1.26% in one year.

Current Share Class	18.07M
Shares Outstanding	18.07M
Shares Change (YoY)	-1.26%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	13.81%
Owned by Institutions (%)	0.02%
Float	12.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.94
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.34
EV / Sales	3.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.27

Financial Position

The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.31.

Current Ratio	6.61
Quick Ratio	6.08
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-1.84
Interest Coverage	-14.92

Financial Efficiency

Return on equity (ROE) is -11.32% and return on invested capital (ROIC) is -5.51%.

Return on Equity (ROE)	-11.32%
Return on Assets (ROA)	-5.41%
Return on Invested Capital (ROIC)	-5.51%
Return on Capital Employed (ROCE)	-9.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.07
Inventory Turnover	2.77

Taxes

In the past 12 months, Genolution has paid 416.85 million in taxes.

Income Tax	416.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.89% in the last 52 weeks. The beta is -0.01, so Genolution's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-35.89%
50-Day Moving Average	2,294.40
200-Day Moving Average	2,429.50
Relative Strength Index (RSI)	45.39
Average Volume (20 Days)	39,719

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genolution had revenue of KRW 7.94 billion and -8.94 billion in losses. Loss per share was -495.05.

Revenue	7.94B
Gross Profit	2.58B
Operating Income	-9.48B
Pretax Income	-9.01B
Net Income	-8.94B
EBITDA	-7.27B
EBIT	-9.48B
Loss Per Share	-495.05

Balance Sheet

The company has 33.80 billion in cash and 24.21 billion in debt, giving a net cash position of 9.60 billion or 531.11 per share.

Cash & Cash Equivalents	33.80B
Total Debt	24.21B
Net Cash	9.60B
Net Cash Per Share	531.11
Equity (Book Value)	78.39B
Book Value Per Share	4,325.62
Working Capital	32.60B

Cash Flow

In the last 12 months, operating cash flow was -4.24 billion and capital expenditures -8.93 billion, giving a free cash flow of -13.17 billion.

Operating Cash Flow	-4.24B
Capital Expenditures	-8.93B
Free Cash Flow	-13.17B
FCF Per Share	-728.98

Margins

Gross margin is 32.51%, with operating and profit margins of -119.39% and -112.56%.

Gross Margin	32.51%
Operating Margin	-119.39%
Pretax Margin	-113.40%
Profit Margin	-112.56%
EBITDA Margin	-91.48%
EBIT Margin	-119.39%
FCF Margin	n/a

Dividends & Yields

Genolution does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.26%
Shareholder Yield	n/a
Earnings Yield	-22.80%
FCF Yield	-33.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 19, 2023. It was a forward split with a ratio of 2.

Last Split Date	Apr 19, 2023
Split Type	Forward
Split Ratio	2

Scores

Genolution has an Altman Z-Score of 2.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.19
Piotroski F-Score	2